Utility and Safety of Perampanel in Pediatric FIRES and Other Drug-Resistant Epilepsies
Perampanel is a novel antiepileptic drug, which antagonises AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) glutamate receptor. We describe perampanel as an adjunctive treatment for FIRES (febrile infection-related epilepsy syndrome) and other drug-resistant epilepsies. A single-cent...
Guardado en:
Autores principales: | Guo Yong Lim BSc(Pharm.)(Hons.), Chun Liang Chen PharmD, BCPPS, Derrick Chan Wei Shih MCI |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fbd11a58dee249bcbf5074a81317f09a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of COVID on pediatrics. “AEP’s pandemic term”
por: Maria José Mellado
Publicado: (2021) -
Pediatric eosinophilic esophagitis: a review for the clinician
por: Simona Barni, et al.
Publicado: (2021) -
Weight Change for Pediatric Completers in a National Weight Loss Program
por: Rochelle Cason-Wilkerson MD, MPH, et al.
Publicado: (2021) -
Simulation during COVID-19 pandemic in the Spanish pediatric intensive care units: New challenges in medical education
por: Laura Butragueño Laiseca, et al.
Publicado: (2021) -
Utility of the Infantile Hemangioma Referral Score (IHReS) as a decision-making tool for referral to treatment
por: Leelawadee Techasatian, et al.
Publicado: (2021)